BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Abstract Background Cystic fibrosis (CF) is a rare, inherited, life-limiting condition predominantly affecting the lungs, for which there is no cure. The disease is characterized by recurrent pulmonary exacerbations (PEx), which are thought to drive progressive lung damage. Management of these episo...
Main Authors: | Andre Schultz, Charlie McLeod, Scott Berry, Julie Marsh, Anne McKenzie, Mitch Messer, Jamie Wood, Ben Saville, Adam Jaffe, Sarath Ranganathan, Steve Stick, Peter Wark, Steve Webb, Tom Snelling |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07076-8 |
Similar Items
-
Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
by: Alfian Nurfaizi, et al.
Published: (2021-05-01) -
Exhaled nitric oxide in acute exacerbation of pediatric asthma
by: Ratnawati Ratnawati, et al.
Published: (2008-05-01) -
Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD
by: Ke X, et al.
Published: (2016-07-01) -
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
by: Henrik Watz, et al.
Published: (2018-12-01) -
Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations
by: Afia Aziz-Ur-Rehman, et al.
Published: (2017-04-01)